PFIZER,MYLAN SEAL DEAL
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2cnXB49uUyUXsUizw6HdOHcCfhdhFyJUe7R-a-ofODhOiyobIi4DtE9LHKoQAEXQtsZHK6HxDY5btwaGottpjc2HSqWgtd60zliC26JMlE2Owq_Q9RESOQx4CHNWZU5Ocw-tfuD7eot0/s1600/pfizer.jpg)
Pfizer agreed on Monday to combine its off-patent drugs division ,which controls treatments such as the statin Lipitor ,with pharmaceutical company Mylan ,creating a potential powerhouse in the business of medicines without patent protections. The transaction comes as falling prices increase pressure on generic drug makers,a development that has been mostly overlooked in the US as a consumers grapple with the escalating price of branded treatments.The deal also raises questions about whether it will spur other acquisitions in the sector . Generic drugmakers such as Mylan and Tava have struggled in part because pharmacies and wholesalers have been teaming up, increasing their power to bargain for lower prices .that has forced such companies to consider mergers as a way to regain leverage . ...